Annual Drug Patent Expirations for BYDUREON+BCISE
Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-one patents protecting this drug.
BYDUREON BCISE drug price trends.
Drug patent litigation for BYDUREON BCISE.
This drug has four hundred and fifty-eight patent family members in forty-eight countries.
The generic ingredient in BYDUREON BCISE is exenatide. One supplier is listed for this compound. Additional details are available on the exenatide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
